Реферат
SUMMARY: Studies have shown the adverse effects of epileptic seizures on reproductive health. The aim of the present study was to investigate morphological changes, apoptosis and GABA localization in the testis tissue of genetic absence epilepsy rats. Testis tissues of GAERS and Wistar rats were processed for paraffin embedding and electron microscopy. Sections were stained with hematoxylin and eosin, Masson's trichrome and periodic acid-Schiff reaction. GABA immunohistochemistry was applied for determining the alterations in GABA levels. GABA immunoreactivity was observed in the seminiferous tubules and interstitial areas of both GAERS and Wistar rats. GABA immunoreactivity was found to be decreased in GAERS compared to Wistar group. Electron microscopic observations showed that GABA was present in manchette microtubules, sperm tail and neck at different phases of spermiogenesis. Qualitative observations revealed that testis tissues of GAERS showed reduced sperm in the seminiferous tubules compared to the Wistar controls. In conclusion, we demonstrated GABAergic system in the seminiferous tubules of control and GAERS rats, in parallel with the previous studies; and there were alterations in this system in GAERS. We suggest that these alterations in absence epilepsy may also affect the gonadal system, resulting in decreased sperm production.
RESUMEN: Los estudios han demostrado los efectos adversos de las convulsiones epilépticas sobre la salud reproductiva. El objetivo del presente estudio fue investigar los cambios morfológicos, la apoptosis y la localización de GABA en el tejido testicular de ratas con epilepsia de ausencia genética. Se procesaron tejidos testiculares de ratas GAERS y Wistar para inclusión en parafina y microscopía electrónica. Las secciones se tiñeron con hematoxilina y eosina, tricrómico de Masson y reacción de ácido peryódico de Schiff. Se aplicó inmunohistoquímica de GABA para determinar las alteraciones en los niveles de GABA. Se observó inmunorreactividad de GABA en los túbulos seminíferos y las áreas intersticiales de las ratas GAERS y Wistar. Se encontró que la inmunorreactividad de GABA estaba disminuida en GAERS en comparación con el grupo Wistar. Las observaciones microscópicas electrónicas mostraron que GABA estaba presente en los microtúbulos, la cola y el cuello del espermatozoide en diferentes fases de la espermiogénesis. Las observaciones cualitativas revelaron que los tejidos testiculares de GAERS mostraron una reducción de los espermatozoides en los túbulos seminíferos en comparación con los controles Wistar. En conclusión, demostramos el sistema GABAérgico en los túbulos seminíferos de ratas control y GAERS, en paralelo con estudios previos; y además se observaron alteraciones en este sistema en GAERS. Sugerimos que estas alteraciones en epilepisa de ausencia genética también pueden afectar el sistema gonadal, resultando en una disminución de la producción de semen.
Тема - темы
Animals , Pregnancy , Rats , Testis/metabolism , Epilepsy, Absence , gamma-Aminobutyric Acid/metabolism , Testis/ultrastructure , Immunohistochemistry , Microscopy, Electron , Rats, WistarРеферат
Abstract Purpose: To investigate the effects of dexmedetomidine (DEX) on amino acid contents and the cerebral ultrastructure of rats with cerebral ischemia-reperfusion injury (I/R). Methods: Thirty-six, male, Wistar rats were randomly divided into three groups: the sham operation group (group C), the ischemia-reperfusion group (group I/R), and the DEX group (group D). The middle cerebral artery occlusion model was prepared by the modified Longa method. The time of ischemia was 180 min, and 120 min after reperfusion, the amount of glutamate (Glu), and γ-aminobutyric acid (GABA) in the brain were measured, and the ultrastructure-level changes in the cerebral cortex were examined using electron microscopy. Results: Compared to group C, Glu contents in group D, and I/R significantly increased. Compared to group I/R, Glu contents in group D significantly decreased. Compared to group C, GABA contents in group D, and I/R significantly increased, and those in group D significantly increased, as compared to group I/R. The cerebral ultrastructure was normal in group C. Vacuolar degeneration in the plastiosome and nervous processes, was more critical than in group D. Vascular endothelial cells (VEC) were damaged. On the contrary, these changes in group D significantly improved. Conclusion: Dexmedetomidine is capable of decreasing glutamergic content, and increasing GABAergic content, in order to decrease the injury of the cerebral ultrastructure, following cerebral ischemia-reperfusion injury.
Тема - темы
Animals , Male , Rats , Reperfusion Injury/metabolism , Cerebral Cortex/chemistry , Brain Ischemia/drug therapy , Neuroprotective Agents/pharmacology , Dexmedetomidine/pharmacology , Glutamine/metabolism , Cerebral Cortex/ultrastructure , Brain Ischemia/metabolism , Rats, Wistar , gamma-Aminobutyric Acid/drug effects , gamma-Aminobutyric Acid/metabolism , Amino Acids/drug effects , Amino Acids/metabolismРеферат
BACKGROUND: It has been proposed that the γ-aminobutyric acid (GABA) plays a key role in the regulation of food intake and body weight by controlling the excitability, plasticity and the synchronization of neuronal activity in the frontal cortex (FC). It has been also proposed that the high-fat diet (HFD) could disturb the metabolism of glutamate and consequently the GABA levels, but the mechanism is not yet clearly understood. Therefore, the aim of this study was to investigate the effect of a HFD on the GABA levels in the FC and hippocampus of rats. RESULTS: The HFD significantly increased weight gain and blood glucose levels, whereas decreased the GABA levels in the FC and hippocampus compared with standard diet-fed rats. CONCLUSIONS: HFD decreases GABA levels in the FC and hippocampus of rat, which likely disrupts the GABAergic inhibitory processes, underlying feeding behavior.
Тема - темы
Animals , Male , Rats , Diet, High-Fat , Frontal Lobe/chemistry , gamma-Aminobutyric Acid/analysis , Hippocampus/chemistry , Reference Values , Blood Glucose/analysis , Body Weight , Weight Gain , Rats, Wistar , Feeding Behavior , Frontal Lobe/metabolism , gamma-Aminobutyric Acid/metabolism , Hippocampus/metabolism , Obesity/metabolismРеферат
According to recent studies, it is highly possible that the occurrence of vesicular inhibitory amino acid transporter (VIAAT) is a good marker of GABA-signaling not only in the brain, but also in extra-brain tissue cells containing GABA and GAD. In view of this, the present study was attempted to localize VIAAT-immunoreactivity in the submandibular gland of mice. In the present study, the submandibular glands of male mice at various postnatal developmental stages were examined for detailed localization of VIAAT-immunoreactivity in immunohistochemistry at light microscopic level. The immunoreactivity for VIAAT was localized in epithelial cells of proximal and distal excretory ducts with the striated portion more intensely immunopositive at young postnatal stages. No significant immunoreactivity was seen in the acinar cells throughout the postnatal development. In addition, the immunoreactivity for VIAAT was detected in the salivary parasympathetic ganglionic neurons, but not in any nerve fibers surrounding the glandular cells. Furthermore, VIAAT-immunoreactivity was found in smooth muscle cells forming the outermost layer of intralobular arterioles. From the present findings, it is possible that GABA plays roles as paracrine and autocrine regulators in the saliva secretion as well as the gland development.
Según estudios recientes, es altamente posible que la aparición del transportador vesicular de aminoácidos inhibidores (VIAAT) sea un buen marcador de señalización de GABA no sólo en el cerebro, sino también en células de tejido extra-cerebrales que contienen GABA y GAD. En el presente estudio se intentó localizar inmunoreactividad a VIAAT en la glándula submandibular de ratones. En el presente estudio, se examinaron las glándulas submandibulares de ratones machos en las distintas etapas del desarrollo postnatal para la localización detallada de inmunoreactividad a VIAAT inmunohistoquímicamente a nivel de microscopía óptica. La inmunorreactividad para VIAAT se localizó en las células epiteliales de los conductos excretores proximal y distal, con mayor intensidad en la porción estriada en las etapas tempranas. No se observó inmunoreactividad significativa en las células acinares durante el desarrollo postnatal. Además, se detectó la inmunoreactividad para VIAAT en las neuronas ganglionares parasimpáticas salivales, pero no en las fibras nerviosas que rodean las células glandulares. Además, la inmunoreactividad a VIAAT se encuentra en las células del músculo liso que forman la capa más externa de las arterias interlobulillares. En base a estos hallazgos, es posible que GABA tenga una función como regulador autocrino y paraparacrino en la secreción de saliva, así como en el desarrollo de la glándula.
Тема - темы
Animals , Male , Mice , Salivary Glands/chemistry , Submandibular Gland/growth & development , Vesicular Inhibitory Amino Acid Transport Proteins/metabolism , gamma-Aminobutyric Acid/metabolism , ImmunohistochemistryРеферат
The catabolism of fungal 4-aminobutyrate (GABA) occurs via succinic semialdehyde (SSA). Succinic semialdehyde dehydrogenase (SSADH) from the acidogenic fungus Aspergillus niger was purified from GABA grown mycelia to the highest specific activity of 277 nmol min-1 mg-1, using phenyl Sepharose and DEAE Sephacel chromatography. The purified enzyme was specific for its substrates SSA and NAD+. The substrate inhibition observed with SSA was uncompetitive with respect to NAD+. While product inhibition by succinate was not observed, NADH inhibited the enzyme competitively with respect to NAD+ and noncompetitively with respect to SSA. Dead-end inhibition by AMP and p-hydroxybenzaldehyde (pHB) was analyzed. The pHB inhibition was competitive with SSA and uncompetitive with NAD+; AMP competed with NAD+. Consistent with the kinetic data, a sequential, ordered Bi Bi mechanism is proposed for this enzyme.
Тема - темы
Adenosine Monophosphate/metabolism , Adenosine Monophosphate/pharmacology , Aspergillus niger/enzymology , Aspergillus niger/metabolism , Benzaldehydes/metabolism , Benzaldehydes/pharmacology , Binding, Competitive , Biocatalysis/drug effects , Fungal Proteins/isolation & purification , Fungal Proteins/metabolism , Kinetics , Mycelium/enzymology , Mycelium/metabolism , NAD/metabolism , NAD/pharmacology , Protein Binding , Substrate Specificity , Succinate-Semialdehyde Dehydrogenase/isolation & purification , Succinate-Semialdehyde Dehydrogenase/metabolism , gamma-Aminobutyric Acid/analogs & derivatives , gamma-Aminobutyric Acid/metabolism , gamma-Aminobutyric Acid/pharmacologyРеферат
Sepsis and the multiorgan dysfunction syndrome are among the most common reasons for admission to an intensive care unit, and are a leading cause of death. During sepsis, the central nervous system (CNS) is one of the first organs affected, and this is clinically manifested as sepsis-associated encephalopathy (SAE). It is postulated that the common final pathway that leads to SAE symptoms is the deregulation of neurotransmitters, mainly acetylcholine. Thus, it is supposed that inflammation can affect neurotransmitters, which is associated with SAE development. In this review, we will cover the current evidence (or lack thereof) for the mechanisms by which systemic inflammation interferes with the metabolism of major CNS neurotransmitters, trying to explain how systemic inflammation drives the brain crazy.
Тема - темы
Humans , Brain/physiopathology , Encephalitis/physiopathology , Sepsis-Associated Encephalopathy/physiopathology , Sepsis/physiopathology , Amines/metabolism , Brain/metabolism , Central Nervous System/metabolism , Central Nervous System/physiopathology , Cytokines/metabolism , Encephalitis/metabolism , Sepsis-Associated Encephalopathy/metabolism , Sepsis/metabolism , gamma-Aminobutyric Acid/metabolismРеферат
Epilepsy is a neurological disorder associated with excitatory and inhibitory imbalance within the underlying neural network. This study evaluated inhibitory γ-amino-butyric acid (GABA)ergic modulation in the CA1 region of the hippocampus of male Wistar rats and Wistar audiogenic rats (aged 90 ± 3 days), a strain of inbred animals susceptible to audiogenic seizures. Field excitatory postsynaptic potentials and population spike complexes in response to Schaffer collateral fiber stimulation were recorded in hippocampal slices before and during application of picrotoxin (50 µM, 60 min), a GABA A antagonist, and the size of the population spike was quantified by measuring its amplitude and slope. In control audiogenic-resistant Wistar rats (N = 9), picrotoxin significantly increased both the amplitude of the population spike by 51 ± 19 percent and its maximum slope by 73 ± 21 percent. In contrast, in slices from Wistar audiogenic rats (N = 6), picrotoxin caused no statistically significant change in population spike amplitude (33 ± 46 percent) or slope (11 ± 29 percent). Data are reported as means ± SEM. This result indicates a functional reduction of GABAergic neurotransmission in hippocampal slices from Wistar audiogenic rats.
Тема - темы
Animals , Male , Rats , CA1 Region, Hippocampal/drug effects , Epilepsy/metabolism , GABA Antagonists/pharmacology , Picrotoxin/pharmacology , Synaptic Transmission/drug effects , gamma-Aminobutyric Acid/metabolism , CA1 Region, Hippocampal/metabolism , Neural Inhibition/drug effects , Neural Inhibition/physiology , Rats, Wistar , Synapses/drug effects , Synapses/physiologyРеферат
Electrical stimulation has been used for more than 100 years in neuroscientific and biomedical research as a powerful tool for controlled perturbations of neural activity. Despite quickly driving neuronal activity, this technique presents some important limitations, such as the impossibility to activate or deactivate specific neuronal populations within a single stimulation site. This problem can be avoided by pharmacological methods based on the administration of receptor ligands able to cause specific changes in neuronal activity. However, intracerebral injections of neuroactive molecules inherently confound the dynamics of drug diffusion with receptor activation. Caged compounds have been proposed to circumvent this problem, for spatially and temporally controlled release of molecules. Caged compounds consist of a protecting group and a ligand made inactive by the bond between the two parts. By breaking this bond with light of an appropriate wavelength, the ligand recovers its activity within milliseconds. To test these compounds in vivo, we recorded local field potentials (LFPs) from the cerebral cortex of anesthetized female mice (CF1, 60-70 days, 20-30 g) before and after infusion with caged γ-amino-butyric-acid (GABA). After 30 min, we irradiated the cortical surface with pulses of blue light in order to photorelease the caged GABA and measure its effect on global brain activity. Laser pulses significantly and consistently decreased LFP power in four different frequency bands with a precision of few milliseconds (P < 0.000001); however, the inhibitory effects lasted several minutes (P < 0.0043). The technical difficulties and limitations of neurotransmitter photorelease are presented, and perspectives for future in vivo applications of the method are discussed.
Тема - темы
Animals , Female , Mice , Cerebral Cortex/metabolism , Cerebral Cortex/physiopathology , Neural Inhibition/physiology , Neurons/physiology , gamma-Aminobutyric Acid/metabolism , Photolysis , gamma-Aminobutyric Acid/chemistryРеферат
Glycine and gamma-aminobutyric acid (GABA) are localized and released by the same interneurons in the spinal cord. Although the effects of glycine and GABA on analgesia are well known, little is known about the effect of GABA in strychnine-induced hyperalgesia. To investigate the effect of GABA and the role of the glycine receptor in thermal hyperalgesia, we designed an experiment involving the injection of muscimol (a GABAA receptor agonist), baclofen (a GABAB receptor agonist) or glycine with strychnine (strychnine sensitive glycine receptor antagonist). Glycine, muscimol, or baclofen with strychnine was injected into the cisterna magna or lumbar subarachnoidal spaces of mice. The effects of treatment on strychnine-induced heat hyperalgesia were observed using the pain threshold index via the hot plate test. The dosages of experimental drugs and strychnine we chose had no effects on motor behavior in conscious mice. Intracisternal or intrathecal administration of strychnine produced thermal hyperalgesia in mice. Glycine antagonize the effects of strychnine, whereas, muscimol or baclofen does not. Our results indicate that glycine has anti-thermal hyperalgesic properties in vivo; and GABA receptor agonists may lack the binding abilities of glycine receptor antagonists with their sites in the central nervous system.
Тема - темы
Animals , Male , Mice , Baclofen/administration & dosage , Drug Delivery Systems , GABA Agonists/administration & dosage , GABA Antagonists/administration & dosage , Glycine/administration & dosage , Hot Temperature , Hyperalgesia/chemically induced , Injections, Spinal , Mice, Inbred ICR , Muscimol/administration & dosage , Pain Threshold , Random Allocation , Strychnine , gamma-Aminobutyric Acid/metabolismРеферат
Expressions of GABA and GABA(A)R-alpha1 in the brain of rats poisoned by Tetramine were analyzed to explore the intoxication mechanism. Methods Sixty rats were randomly divided into control, sham poisoned, high-dose poisoned (1.0 mg/kg tetramine) and low-dose poisoned (0.1 mg/kg) groups. The expressions of GABA and GABA(A)R-alpha1 in the brain of the poisoned rats were detected and analyzed by immunohistochemistry and imaging analyzer. Results The expressions of both GABA and GABA(A)R-alpha1 were diffusely seen in the brains of the control and shame poisoned rat groups with a moderate expression level, whereas the expressions of both GABA and GABA(A)R-alpha1 were decreased in the brains of the high-dose poisoned group. In the low-dose poisoned rat group, the expression of GABA initially decreased and reached its lowest level 6 hours after poisoning, and then started to show an increase and reached the level of control groups at day 3. The expressions level reached its peak at days 5-7 after poisoning and remained above the level of control groups till 10 days after poisoning. Similarly, the expression of GABA(A)R-alpha1 in the brains of the low-dose poisoned group initially decreased and reached its lowest level 6-12 hrs after poisoning, and then started to increase and reached the level of control groups at days 7-10 after poisoning, respectively. Conclusion The expression of both GABA and GABA(A)R-alpha1 decreased in the brains of the high-dose poisoned rat group and these changes of GABA and GABA(A)R-alpha1 expressions may be associated with underlying mechanism of tetramine poisoning.
Тема - темы
Animals , Female , Male , Rats , Brain/pathology , Bridged-Ring Compounds/poisoning , Cerebral Cortex/pathology , Hippocampus/pathology , Immunohistochemistry , Random Allocation , Rats, Sprague-Dawley , Receptors, GABA-A/metabolism , Time Factors , gamma-Aminobutyric Acid/metabolismРеферат
Effect of alcoholic extract of roots of Rubia cordifolia was studied on elevated blood glucose level in alloxan treated animals. The extract reduced the blood sugar level raised by alloxan. Effect of alcoholic extract was also investigated on cold restraint induced stress and on scopolamine-induced memory impairment. Alcoholic extract enhanced brain gamma-amino-n-butyric acid (GABA) levels and decreased brain dopamine and plasma corticosterone levels. Acidity and ulcers caused due to cold restraint stress were inhibited by alcoholic extract. Animals treated with alcoholic extract spent more time in open arm in elevated plus maze model. It also antagonized scopolamine induced learning and memory impairment. Baclofen induced catatonia was potentiated by alcoholic extract.
Тема - темы
Animals , Blood Glucose/analysis , Corticosterone/blood , Dopamine/metabolism , Female , Hypoglycemic Agents/pharmacology , Male , Mice , Nootropic Agents/pharmacology , Plant Extracts/pharmacology , Plant Roots/chemistry , Rubia/chemistry , Stress, Physiological/prevention & control , gamma-Aminobutyric Acid/metabolismРеферат
Corticotropin releasing factor (CRF) is known to be involved in the stress response and in some degenerative brain disorders. In addition, CRF has a role as a neuromodulator in adult cerebellar circuits. Data from developmental studies suggest a putative role for CRF as a trophic factor during cerebellar development. In this study, we investigated the trophic role for CRF family of peptides by culturing cerebellar neurons in the presence of CRF, urocortin or urocortin II. Primary cell cultures of cerebella from embryonic day 18 mice were established, and cells were treated for either 1, 5 or 9 days with Basal Medium Eagles complete medium alone or complete medium with 1 micrometer CRF, urocortin, or urocortin II. The number of GABA-positive neurons in each treatment condition was counted at each culture age for monitoring the changes in neuronal survival. Treatment with 1 micrometer CRF or 1 micrometer urocortin increased the survival of GABAergic neurons at 6 days in vitro and 10 days in vitro, and this survival promoting effect was abolished by treatment with astressin in the presence of those peptides. Based on these data, we suggest that CRF or urocortin has a trophic role promoting the survival of cerebellar GABAergic neurons in cultures.
Тема - темы
Mice , Animals , gamma-Aminobutyric Acid/metabolism , Time Factors , Receptors, Corticotropin-Releasing Hormone/metabolism , Peptides/chemistry , Neurons/metabolism , Mice, Inbred C57BL , Immunohistochemistry , Image Processing, Computer-Assisted , Corticotropin-Releasing Hormone/biosynthesis , Cerebellum/embryology , Cells, Cultured , Cell SurvivalРеферат
Alcohol dependence is a chronic disorder that results from a variety of genetic, psychosocial, and environmental factors. Relapse prevention for alcohol dependence has traditionally involved psychosocial and psychotherapeutic interventions. Pharmacotherapy, however, in conjunction with behavioral therapy, is generating interest as another modality to prevent relapse and enhance abstinence. Naltrexone and acamprosate are at the forefront of the currently available pharmacological options. Naltrexone is an opioid receptor antagonist and is thought to reduce the rewarding effect of alcohol. Acamprosate normalizes the dysregulation of N-methyl-D-aspartate (NMDA)-mediated glutamatergic excitation that occurs in alcohol withdrawal and early abstinence.These different mechanisms of action and different target neurotransmitter systems may endow the two drugs with efficacy for different aspects of alcohol use behavior. Since not all patients seem to benefit from naltrexone and acamprosate, there are ongoing efforts to improve the treatment outcomes by examining the advantages of combined pharmacotherapy and exploring the variables that might predict the response of the medications. In addition, novel medications are being investigated to assess their efficacy in preventing relapse and increasing abstinence.
Тема - темы
Humans , gamma-Aminobutyric Acid/metabolism , Taurine/analogs & derivatives , Recurrence , Receptors, Opioid, mu/genetics , Receptors, Opioid/antagonists & inhibitors , Polymorphism, Genetic , Neurons/metabolism , Naltrexone/therapeutic use , N-Methylaspartate/metabolism , Models, Neurological , Models, Biological , Glutamine/metabolism , Disulfiram/therapeutic use , Alcoholism/drug therapy , Alcohol Deterrents/therapeutic useРеферат
A pesar de los avances en el conocimiento de las bases biológicas de la conducta, los mecanismos neurobiológicos precisos involucrados en la esquizofrenia permanecen desconocidos. Como consecuencia de esto las terapias farmacológicas actuales descansan más sobre bases empíricas que sobre explicaciones fisiopatológicas. En el presente trabajo se propone un modelo de la esquizofrenia que podría ser de utilidad en el diseño de nuevas estrategias terapéuticas. Este modelo intenta integrar recientes hallazgos neuropsicológicos y de neuroimagen con lo que hoy sabemos respecto a la biología del desarrollo y plasticidad cerebral normal. Se propone que la esquizofrenia es una enfermedad del neurodesarrollo caracterizada por una neurotransmisión glutamatérgica inadecuadamente modulada a consecuencia de la disfunción de interneuronas GABAérgicas en múltiples regiones del cerebro. Anormalidades sutiles en el balance entre GABA y Glutamato explicarían los defectos en la cognición, la conducta social y la coordinación motora reportados en las etapas pre-psicóticas de la esquizofrenia. Más tarde en la historia natural de la enfermedad, estados hiperglutamatérgicos desencadenados por la incrementada neurotransmisión dopaminérgica propia de la peri-adolescencia y adultez temprana llevarían a la psicosis. Esta excesiva actividad glutamatérgica conduciría a su vez a las reducciones progresivas en sustancia gris y blanca observadas en recientes estudios prospectivos. En apoyo a esta hipótesis, se describen estudios propios y de otros laboratorios con pacientes esquizofrénicos, así como en un modelo animal de exposición intermitente a fenciclidina. Como corolario, drogas moduladoras de la neurotransmisión glutamatérgica, tales como acamprosato y lamotrigina, son propuestas como estrategias terapéuticas potencialmente utilizables en las etapas tempranas de la esquizofrenia.
Тема - темы
Animals , Humans , Schizophrenia/genetics , Schizophrenia/metabolism , Glutamic Acid/metabolism , gamma-Aminobutyric Acid/metabolism , Antipsychotic Agents/therapeutic use , Disease Models, Animal , Dopamine/metabolism , Schizophrenia/physiopathology , Schizophrenia/drug therapy , Phencyclidine/pharmacology , Neurotransmitter Agents , Psychoses, Substance-Induced , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitorsРеферат
To investigate the effect of thiopental sodium on the release of glutamate and gamma-aminobutyric acid (GABA) from synaptosomes in the prefrontal cortex, synaptosomes were made, the spontaneous release and the evoked release by 30 mmol/L KCl or 20 micromol/L veratridine of glutamate and GABA were performed under various concentrations of thiopental sodium (10-300 micromol/L), glutamate and GABA concentrations were determined by reversed-phase high-performance liquid chromatography. Our results showed that spontaneous release and evoked release of glutamate were significantly inhibited by 30 micromol/L, 100 micromol/L and 300 micromol/L thiopental sodium, IC50 of thiopental sodium was 25.8 +/- 2.3 micromol/L for the spontaneous release, 23.4 +/- 2.4 micromol/L for KCl-evoked release, and 24.3 +/- 1.8 micromol/L for veratridine-evoked release. But GABA spontaneous release and evoked release were unaffected. The study showed that thiopental sodium with clinically related concentrations could inhibit the release of glutamate, but had no effect on the release of GABA from rats prefrontal cortical synaptosomes.
Тема - темы
Glutamic Acid/metabolism , Hypnotics and Sedatives/pharmacology , Prefrontal Cortex/metabolism , Rats, Sprague-Dawley , Synaptosomes/metabolism , Thiopental/pharmacology , gamma-Aminobutyric Acid/metabolismРеферат
The Pogo mouse is an autosomal recessive ataxic mutant that arose spontaneously in the inbred KJR/MsKist strain derived originally from Korean wild mice. The ataxic phenotype is characterized by difficulty in maintaining posture and side to side stability, faulty coordination between limbs and trunk, and the consequent inability to walk straight. In the present study, the cerebellar concentrations of glutamate and GABA were analyzed, since glutamate is a most prevalent excitatory neurotransmitter whereas gammar-aminobutyric acid (GABA) is one of the most abundant inhibitory neurotransmitters, which may be the main neurotransmitters related with the ataxia and epilepsy. The concentration of glutamate of cerebellum decreased significantly in ataxic mutant Pogo mouse compared to those of control mouse. However, GABA concentration was not decrease. These results suggested that the decrease in glutamate concentration may contribute to ataxia in mutant Pogo mouse.
Тема - темы
Animals , Mice , S100 Calcium Binding Protein G/metabolism , Cerebellum/metabolism , Gait Ataxia/metabolism , Glutamic Acid/metabolism , Immunohistochemistry , Mice, Mutant Strains , gamma-Aminobutyric Acid/metabolismРеферат
Despite extensive genetic and immunological research, the complex etiology and pathogenesis of type I diabetes remains unresolved. During the last few years, our attention has been focused on factors such as abnormalities of islet function and/or microenvironment, that could interact with immune partners in the spontaneous model of the disease, the non-obese diabetic (NOD) mouse. Intriguingly, the first anomalies that we noted in NOD mice, compared to control strains, are already present at birth and consist of 1) higher numbers of paradoxically hyperactive ß cells, assessed by in situ preproinsulin II expression; 2) high percentages of immature islets, representing islet neogenesis related to neonatal BETA-cell hyperactivity and suggestive of in utero BETA-cell stimulation; 3) elevated levels of some types of antigen-presenting cells and FasL+ cells, and 4) abnormalities of extracellular matrix (ECM) protein expression. However, the colocalization in all control mouse strains studied of fibroblast-like cells (anti-TR-7 labeling), some ECM proteins (particularly, fibronectin and collagen I), antigen-presenting cells and a few FasL+ cells at the periphery of islets undergoing neogenesis suggests that remodeling phenomena that normally take place during postnatal pancreas development could be disturbed in NOD mice. These data show that from birth onwards there is an intricate relationship between endocrine and immune events in the NOD mouse. They also suggest that tissue-specific autoimmune reactions could arise from developmental phenomena taking place during fetal life in which ECM-immune cell interaction(s) may play a key role
Тема - темы
Humans , Animals , Female , Mice , Child , Diabetes Mellitus, Type 1/etiology , Pancreas/growth & development , Pancreas/physiopathology , Antigen-Presenting Cells/metabolism , Antigen-Presenting Cells/physiology , Apoptosis , Extracellular Matrix/metabolism , gamma-Aminobutyric Acid/metabolism , Islets of Langerhans/immunology , Islets of Langerhans/physiopathology , Mice, Inbred NOD , Pancreas/embryologyРеферат
A gabapentina e uma nova substancia analoga ao acido gama-aminoburitico (GABA). Tem-se demonstrado efetiva como terapia adjuvante em convulsoes parciais e no tratamento de algumas neuralgias, assim como em algumas afeccoes psiquiatricas. Possui a vantagem de nao ter metabolismo hepatico, nao se ligar a proteinas plasmaticas, possui poucos efeitos adversos e potencial muito baixo para interacoes medicamentosas.
Тема - темы
gamma-Aminobutyric Acid/pharmacology , Drug Interactions , gamma-Aminobutyric Acid/metabolism , gamma-Aminobutyric Acid/therapeutic useРеферат
Effect of a triterpene isolated from the acetone soluble part of petroleum ether extract of R. cordifolia was studied on convulsions induced by maximum electro shock (MES), electrical kindling and various chemoconvulsants in rats and mice. The effect of triterpene was also investigated on behavior and gamma-aminobutyric acid (GABA) and serotonin (5-HT) content in mouse brain. Triterpene inhibited seizures induced by MES, electrical kindling, pentylenetetrazol (PTZ), and lithium-pilocarpine. However, seizures induced by strychnine were not inhibited. Triterpene reduced locomotion as well as rearing. Pentobarbitone induced sleep was potentiated and amphetamine induced stereotypy was inhibited. The triterpene was found to possess anxiogenic activity. Brain GABA and 5-HT contents were raised by the compound. The study suggests that the triterpene isolated from R. cordifolia bear a potential for further study.
Тема - темы
Animals , Anticonvulsants/isolation & purification , Behavior, Animal/drug effects , Brain/drug effects , Female , Male , Mice , Rats , Rubiaceae/chemistry , Serotonin/metabolism , Triterpenes/isolation & purification , gamma-Aminobutyric Acid/metabolismРеферат
Depression is a common psychiatric disorder prevalent in 10-15% in general population. To know the biology of the disease many hypotheses have been proposed. Genetic basis for depression is provided by family studies which show higher risk of depression among first degree relatives. Abnormalities in serotonergic activity in depression can occur in one or more levels. Other neurotransmitters like gamma amino butyric acid (GABA) and dopamine are also considered to have some role in depression. Hormonal abnormalities like hypercortisolaemia are found in patients with depression. Structural and functional neuro-imaging studies in depression suggest the involvement of brain in depressive disorders.